Literature DB >> 24000236

Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells.

Arianna Di Napoli1, Mazin F Al-Jadiri, Caterina Talerico, Enrico Duranti, Emanuela Pilozzi, Pankaj Trivedi, Eleni Anastasiadou, Adel R Alsaadawi, Amir F Al-Darraji, Salma A Al-Hadad, Anna Maria Testi, Stefania Uccini, Luigi Ruco.   

Abstract

BACKGROUND: Classical Hodgkin lymphoma (cHL) in children is often associated with EBV infection, more commonly in developing countries. PROCEDURE: Here we describe the histological, immunohistochemical, and molecular features of 57 cases of HL affecting Iraqi children under 14 years of age.
RESULTS: Histologically, 51 cases were classified as cHL of Mixed Cellularity and Nodular Sclerosis subtypes (MC = 69%; NS = 31%), and 6 cases as Nodular Lymphocyte Predominant HL (NLP-HL). EBV infection of H/RS cells was demonstrated in 44 of 51 cases of cHL (86%), and was more common in MC than in NS (97% vs. 63%; P = 0.0025). The immunophenotypic profile of H/RS cells was similar in MC and NS, and was not influenced by EBV infection; H/RS cells were consistently positive for PAX-5 and to a lesser degree for other B cell markers including CD20/CD79a, OCT-2, and BOB-1. Clonal IGH rearrangements were detected in 14 of 38 cHL (37%), with no significant difference between MC and NS cases, and with no association with the EBV status. Oligoclonal/monoclonal TCRγ rearrangements were present in 28 of 38 cases (74%), suggestive of restricted T cell responses.
CONCLUSIONS: Our findings indicate that cHL occurring in Iraqi children is characterized by immunohistochemical and molecular features undistinguishable from those present in cHL occurring elsewhere in the world. Moreover, the high incidence of EBV-infected H/RS cells and frequent occurrence of restricted T cell responses might be indicative of a defective local immune response perhaps related to the very young age of the children.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Epstein-Barr virus (EBV); Hodgkin lymphoma; IGH gene rearrangement; Iraqi children; TCRγ gene rearrangement; restricted T cell response

Mesh:

Substances:

Year:  2013        PMID: 24000236     DOI: 10.1002/pbc.24654

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  8 in total

1.  BOB.1-positive Classical Hodgkin's Lymphoma Carries Hypermethylation of Its Promoter as Epigenetic Marker of Gene-silencing Memory.

Authors:  Takafumi Watanabe; Riko Kitazawa; Yosuke Mizuno; Natsumi Kuwahara; Chizu Ito; Atsuro Sugita; Ryuma Haraguchi; Sohei Kitazawa
Journal:  Acta Histochem Cytochem       Date:  2014-06-26       Impact factor: 1.938

2.  Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma.

Authors:  Arianna Di Napoli; Giuseppina Pepe; Enrico Giarnieri; Claudia Cippitelli; Adriana Bonifacino; Mauro Mattei; Maurizio Martelli; Carlo Falasca; Maria Christina Cox; Iolanda Santino; Maria Rosaria Giovagnoli
Journal:  PLoS One       Date:  2017-07-17       Impact factor: 3.240

3.  Epstein Barr Virus-Associated Hodgkin Lymphoma.

Authors:  Antonino Carbone; Annunziata Gloghini
Journal:  Cancers (Basel)       Date:  2018-05-25       Impact factor: 6.639

4.  Clinicopathological significance of CD79a expression in classic Hodgkin lymphoma.

Authors:  Akio Sakatani; Takuro Igawa; Takeshi Okatani; Megumu Fujihara; Hideki Asaoku; Yasuharu Sato; Tadashi Yoshino
Journal:  J Clin Exp Hematop       Date:  2020-07-08

5.  Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo.

Authors:  Eleni Anastasiadou; Anita G Seto; Xuan Beatty; Melanie Hermreck; Maud-Emmanuelle Gilles; Dina Stroopinsky; Lauren C Pinter-Brown; Linda Pestano; Cinzia Marchese; David Avigan; Pankaj Trivedi; Diana M Escolar; Aimee L Jackson; Frank J Slack
Journal:  Clin Cancer Res       Date:  2020-11-18       Impact factor: 13.801

Review 6.  The Nefarious Nexus of Noncoding RNAs in Cancer.

Authors:  Eleni Anastasiadou; Alberto Faggioni; Pankaj Trivedi; Frank J Slack
Journal:  Int J Mol Sci       Date:  2018-07-17       Impact factor: 5.923

Review 7.  Epstein-Barr Virus and Helicobacter Pylori Co-Infection in Non-Malignant Gastroduodenal Disorders.

Authors:  Ramsés Dávila-Collado; Oscar Jarquín-Durán; Le Thanh Dong; J Luis Espinoza
Journal:  Pathogens       Date:  2020-02-06

8.  Epstein-Barr Virus BBRF2 Is Required for Maximum Infectivity.

Authors:  H M Abdullah Al Masud; Yusuke Yanagi; Takahiro Watanabe; Yoshitaka Sato; Hiroshi Kimura; Takayuki Murata
Journal:  Microorganisms       Date:  2019-12-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.